BBL
DGX icon

Beck Bode LLC’s Quest Diagnostics DGX Stock Holding History

Beck Bode LLC’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Buy
+1,751
New +$344K 0.06% 72
2021
Q4 		– Sell
-3,132
Closed -$455K – 89
2021
Q3 		$455K Buy
3,132
+60
+2% +$8.78K 0.13% 66
2021
Q2 		$405K Buy
3,072
+991
+48% +$130K 0.11% 62
2021
Q1 		$267K Buy
+2,081
New +$256K 0.08% 57
2020
Q4 		– Sell
-1,781
Closed -$204K – 79
2020
Q3 		$204K Buy
+1,781
New +$210K 0.07% 54

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Beck Bode LLC's DGX Position: Q2 2026 in Review

Beck Bode LLC opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,751 shares worth $371K. The stake represents 0.06% of the portfolio and ranks #72 among its holdings. This is a return to the name: Beck Bode LLC previously reported a position in DGX as recently as Q3 2021.

Beck Bode LLC first reported a position in DGX in Q3 2020 and has held it in 5 quarters since. The position peaked at $455K in Q3 2021. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Beck Bode LLC held 1,751 shares of Quest Diagnostics worth $371K as of Q2 2026.
  • Quest Diagnostics was a new Beck Bode LLC position in Q2 2026.
  • Quest Diagnostics made up 0.06% of Beck Bode LLC's portfolio in Q2 2026, its #72 holding.
  • Beck Bode LLC first reported a position in Quest Diagnostics in Q3 2020 and has held it in 5 quarters since.
  • Beck Bode LLC's Quest Diagnostics position peaked at $455K in Q3 2021.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Beck Bode LLC's 13F filing for Q2 2026, filed 13 Aug 2026.